Resolvin E1 heals injured cardiomyocytes: Therapeutic implications and H-FABP as a readout for cardiovascular disease & systemic inflammation
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resolvin E1 heals injured cardiomyocytes: Therapeutic implications and H-FABP as a readout for cardiovascular disease & systemic inflammation
Authors
Keywords
-
Journal
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
Volume 197, Issue -, Pages 102586
Publisher
Elsevier BV
Online
2023-08-11
DOI
10.1016/j.plefa.2023.102586
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis
- (2023) Lael M. Yonker et al. CIRCULATION
- Long-term cardiovascular outcomes of COVID-19
- (2022) Yan Xie et al. NATURE MEDICINE
- The COVID Heart—One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks
- (2022) Jennifer Abbasi JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hundreds of COVID trials could provide a deluge of new drugs
- (2022) Heidi Ledford NATURE
- Resolvin E1 Reduces Tumor Growth in a Xenograft Model of Lung Cancer
- (2022) Alpdogan Kantarci et al. AMERICAN JOURNAL OF PATHOLOGY
- Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19
- (2022) Sonu Abraham et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro
- (2021) Aimeé Salas-Hernández et al. MOLECULAR BIOLOGY REPORTS
- The chronic kidney disease and acute kidney injury involvement in COVID-19 pandemic: A systematic review and meta-analysis
- (2021) Ya-Fei Liu et al. PLoS One
- Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial
- (2021) Hildur Arnardottir et al. Frontiers in Physiology
- Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes
- (2021) Ilja L. Kruglikov et al. PLoS Pathogens
- Resolution of inflammation: An organizing principle in biology and medicine
- (2021) Dipak Panigrahy et al. PHARMACOLOGY & THERAPEUTICS
- Resolvin E1 Regulates Th17 Function and T Cell Activation
- (2021) Fatma Oner et al. Frontiers in Immunology
- Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients
- (2021) Paula C. Teixeira et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease
- (2021) Stanislav Kotlyarov et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Blood Microbiota and Circulating Microbial Metabolites in Diabetes and Cardiovascular Disease
- (2020) Ganesan Velmurugan et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Correlation between Heart fatty acid binding protein and severe COVID-19: A case-control study
- (2020) Li Yin et al. PLoS One
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury
- (2020) Jishou Zhang et al. Frontiers in Pharmacology
- IMMUNOMETABOLIC STATUS OF COVID-19 CANCER PATIENTS
- (2020) Antonio Sica et al. PHYSIOLOGICAL REVIEWS
- Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19
- (2020) Evangelos Andreakos et al. ALLERGY
- SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes
- (2020) Denisa Bojkova et al. CARDIOVASCULAR RESEARCH
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity
- (2020) Ganna Petruk et al. Journal of Molecular Cell Biology
- Cardiovascular Manifestations of COVID-19 Infection
- (2020) Ajit Magadum et al. Cells
- Omega-3 fatty acids, cardiovascular risk, and the resolution of inflammation
- (2019) Magnus Bäck et al. FASEB JOURNAL
- Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis
- (2018) Xiao-dong Ye et al. ACTA PHARMACOLOGICA SINICA
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro
- (2016) C. Rey et al. BRAIN BEHAVIOR AND IMMUNITY
- Systemic Inflammation: Methodological Approaches to Identification of the Common Pathological Process
- (2016) N. V. Zotova et al. PLoS One
- Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis
- (2015) H. Hasturk et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- β-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels
- (2015) Chuck T. Chen et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Fatty acid‐binding protein as marker for renal injury
- (2008) Maurice M. A. L. Pelsers SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search